Daniel L. Menichella

Daniel L. Menichella is a declared insider at 3 companies; the most frequent names are Talecris Biotherapeutics Holdings Corp., Applied Genetic Technologies Corp and Kaleido Biosciences, Inc. Between 30 September 2009 and 8 February 2021, the trades on record add up to 12 filings.

The open-market side counts 1 purchase for €191k alongside 3 sales for €1.9M. Sales outweigh purchases by €1.7M. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 4 share grants and 3 option exercises. So far in 2021, the count stands at 1 purchase and no sales.

The latest filing, published on 26 February 2021, reports an open-market purchase of €191k in Kaleido Biosciences, Inc. The median gap between a trade and its publication by SEC (Form 4) is 3 days. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.